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ABSTRACT
Histone deacetylase (HDAC) 3, as a cofactor in
co-repressor complexes containing silencing
mediator for retinoid or thyroid-hormone receptors
(SMRT) and nuclear receptor co-repressor (N-CoR),
has been shown to repress gene transcription in a
variety of contexts. Here, we reveal a novel role for
HDAC3 as a positive regulator of IL-1-induced gene
expression. Various experimental approaches
involving RNAi-mediated knockdown, conditional
gene deletion or small molecule inhibitors indicate
a positive role of HDAC3 for transcription of the
majority of IL-1-induced human or murine genes.
This effect was independent from the gene regula-
tory effects mediated by the broad-spectrum HDAC
inhibitor trichostatin A (TSA) and thus suggests
IL-1-specific functions for HDAC3. The stimulatory
function of HDAC3 for inflammatory gene expres-
sion involves a mechanism that uses binding to
NF-iB p65 and its deacetylation at various lysines.
NF-iB p65-deficient cells stably reconstituted to
express acetylation mimicking forms of p65 (p65
K/Q) had largely lost their potential to stimulate
IL-1-triggered gene expression, implying that the
co-activating property of HDAC3 involves the
removal of inhibitory NF-iB p65 acetylations at
K122, 123, 314 and 315. These data describe a
novel function for HDAC3 as a co-activator in in-
flammatory signaling pathways and help to explain
the anti-inflammatory effects frequently observed
for HDAC inhibitors in (pre)clinical use.
INTRODUCTION
Pathogen-associated molecular patterns or damage/
danger-associated molecular patterns are sensed by speciﬁc
receptors, which in turn activate signaling cascades to
induce the synthesis of inﬂammatory mediators such as
tumor necrosis factor (TNF) or interleukin(IL)-1 and
IL-8 (1). Once released, these cytokines in turn stimulate
their cognate receptors and thus mediate the rapid ampli-
ﬁcation of the inﬂammatory response. One central indu-
cible transcription factor system of major importance for
the pro-inﬂammatory gene expression program is NF-kB
(2). It consists of ﬁve different DNA-binding subunits that
occur in different dimer combinations, but a heterodimer
between p50 and the strongly transactivating p65 subunit
is the most frequently detected form (3). The DNA-
binding NF-kB dimer is retained in the cytosol by associ-
ation with an inhibitory IkB protein, thus maintaining
this transcription factor in an inactive status. A plethora
of damage/danger-associated molecular pattern signals
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ranging from proinﬂammatory signals to toxic, physical
and oxidative stresses leads to the phosphorylation and
degradation of IkB and thus allow subsequent nuclear
translocation of the DNA-binding subunits and inducible
gene expression (2,4).
Speciﬁcity in NF-kB-triggered gene expression is
achieved by several mechanisms mainly occurring in the
nucleus. These include the generation of distinct DNA-
binding dimers, interplay between NF-kB and other tran-
scription factors, stimulus-speciﬁc modiﬁcation and
remodeling of chromatin and by posttranslational modiﬁ-
cations (PTMs) of the DNA-binding subunits (4,5).
Although PTMs were reported for all ﬁve members of
the NF-kB family, most information has been gathered
for the p65 subunit, which is modiﬁed by phosphorylation,
monomethylation, degradative and regulatory ubiquiti-
nation, as well as acetylation (6–8). Historically, most of
the PTMs were considered to exert stimulatory functions,
but the underlying evidence is mainly based on the use of
synthetic reporter genes and overexpression systems.
Reconstitution of p65-deﬁcient cells with p65 variants
mutated at individual sites of modiﬁcation has recently
revealed a more complex picture and showed that the
outcome of a given PTM is highly target gene speciﬁc.
This is exempliﬁed by p65 acetylation, which occurs at
several lysines. Although an inhibitory function has
been reported for acetylation at lysines 122 and 123 (9),
overexpression experiments revealed a stimulatory
function for acetylation of lysine 310 (10,11). Recon-
stitution experiments showed that the recently discovered
acetylation sites at lysines 314 and 315 serve to augment or
to dampen NF-kB-dependent transcription in a target
gene-speciﬁc manner (12–14).
The regulation of p65 acetylation is achieved by several
mechanisms. As acetylation and ubiquitination use an
overlapping set of lysines (123, 310 and 314), both com-
peting PTMs were found to inhibit each other (15).
Acetylation of p65 occurs by the histone acetyltransferases
(HATs) CREB-binding protein (CBP)/p300 but also
by p300/CBP-associated factor (PCAF) (9,16–19).
Deacetylation of p65 can be mediated by the histone
deacetylases (HDACs) HDAC1, HDAC2 and HDAC3,
which all belong to the class I family of HDACs with
homology to the budding yeast counterparts Rpd3
(9,19–21). The class III HDACs, SIRT1 and SIRT2, can
also deacetylate p65 (13,22). HDACs are typically found
in large high molecular weight complexes that often
contain other HDACs or accessory proteins important
for the regulation of chromatin, gene expression, RNA
splicing or further functions (21,23).
HDAC3 deacetylates histones in vitro (24) and has been
puriﬁed as a catalytic subunit of SMRT-NCoR containing
nuclear complexes, which mediate nuclear hormone
receptor-dependent transcriptional repression (23,25,26).
These initial observations and follow-up studies have
ﬁrmly established HDAC3 as a transcriptional
co-repressor (27). However, HDAC3 is also present in
the cytoplasm (28) and was found to deacetylate a
variety of protein substrates, suggesting that its physio-
logical functions may reach beyond its role as a
co-repressor (27).
The high number of HDAC3 target proteins also
explains the importance of HDAC3 for several epigenetic
and genetic fundamental processes. Targeted deletion of
HDAC3 showed its contribution to the maintenance of
chromatin structure, genome stability and the cell cycle
(29,30). In addition, organ-speciﬁc deletion revealed its
role in cardiac energy metabolism (31), metabolic tran-
scription networks in the liver (32) and as a critical
regulator of S phase progression and DNA damage
control (33).
Here, we show that the reported anti-inﬂammatory
effects of HDAC inhibitors (34) are at least, in part,
owing to the stimulatory role of HDAC3 for IL-1-
induced gene expression. A variety of biochemical,
pharmacological and genetic approaches showed an im-
portant role of HDAC3 for efﬁcient expression of IL-1
target genes. This effect is mainly mediated by the
HDAC3-mediated deacetylation of NF-kB p65 at lysines
122, 123, 314 and 315.
MATERIALS AND METHODS
Cells and materials
HEK293 cells stably expressing the IL-1 receptor
(HEK293IL-1R) (35), human epithelial carcinoma KB
cells (36), A549 lung epithelial carcinoma cells (catalogue
number ACC 107, German Collection of Microorganisms
and Cell Cultures), mouse embryonic ﬁbroblasts (Mefs)
with a tamoxifen-inducible deletion of HDAC3 (33), p65
NF-kB-deﬁcient and reconstituted Mefs (15), and all other
Mefs lines were cultured in Dulbecco’s modiﬁed Eagle’s
medium, complemented with 10% fetal calf serum, 2mM
L-glutamine, 100U/ml penicillin and 100 mg/ml strepto-
mycin. For the experiments shown in Figure 2 and
Supplementary Figures S3, S6, S10, S11, Hdac3 ﬂ/+ or
Hdac3 ﬂ/ Mefs were immortalized by the 3T3 protocol.
For the experiments shown in Supplementary Figure S2,
wild-type Mef lines obtained from Matthias Gaestel (37)
and from Mitchell A. Lazar (38) were used.
Antibodies against the following proteins or peptides
were used: b-actin (JLA20; EMD), p65 (C-20, sc-372),
HDAC1 (C-19, sc-6298), HDAC3 (H-99, sc-11417), p300
(N15, sc-584) and mouse IgG (sc-2025) from Santa Cruz;
GFP (clone 7.1 and 13.1; 11814460001) and MYC (9E10)
from Roche; acetyl-NF-kB p65 (K310) (3045) and
acetylated lysine antibody (9441) from Cell Signaling;
acetyl-histone H3 (K9/14) (06-599; Upstate), acetyl-NF-
kB p65 (K310) (ab52175) from Abcam; FLAG (clone
M2; F1804) and b-tubulin (clone TUB2.1; T4026) from
Sigma and HDAC3 (mouse monoclonal: MCA4831Z;
AbD Serotec). Antibodies against acetyl-NF-kB p65
(K314) and acetyl-NF-kB p65 (K315) were generated by
Michael O. Hottiger and have been described in (12,14).
TSA, apicidin, tamoxifen and puromycin were from
Sigma. Human recombinant IL-1a was used at 10 ng/ml
in all experiments and was a kind gift from Jeremy
Saklatvala, London, UK. Recombinant human TNFa
was from R&D Systems or Hoelzel. Ni2+-NTA agarose
was from Qiagen (1018244), and True Blot anti-mouse
Ig IP beads were from eBioscience (00-8811-25).
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Plasmids, transfections, reporter gene assays and
selection of stable cell lines
For reporter gene assays the following expression vectors
were used: pUHC13-3-IL-8 promoter and pSV40-
ß-galactosidase (SV40-ß-gal) (39). His-p65, YFP (yellow
ﬂuorescent protein)-CBP, HA-p65 and its various point
mutated derivatives (HA-p65 K310Q / K310R, HA-p65
K4Q / K4R, HA-p65 K5Q / K5R) were described (15).
Additional K-Q mutants of p65, His-p65 E39I and
His-p65 K5R were generated by site-directed mutagenesis
as described (40). HDAC3-HA was a kind gift of Dr.
Edward Seto, Tampa, Florida. Expression vectors for
p300, HDAC1, HDAC2, HDAC5, HDAC8 have been
described.
Transient transfections by the calcium phosphate
method and determination of luciferase reporter gene
activity were performed as described previously (40).
Equal amounts of plasmid DNA within each experiment
were obtained by adding empty vector.
For establishing a stable knockdown of HDAC3,
HEK293IL-1R cells were transfected with Sure
SilencingTM shRNA plasmids against human HDAC3
(clone ID3) (Superarray Biosciences; KH05911P) or an
empty control vector (pSuper-Puro) as negative control,
using the calcium phosphate method. Twenty-four hours
post transfection, selection was started using 0.75 mg/ml
puromycin, and stable cell lines were isolated. KB cells
were stably transfected with the same plasmids using
Lipofectamine (InvitrogenTM) and also selected in
0.75mg/ml puromycin.
Cell lysis and coimmunoprecipitation
HEK293IL-1R cell lines with a partial shRNA-mediated
knockdown of HDAC3 (Figure 1A) were harvested after
washing in cold phosphate-buffered saline (PBS) and col-
lected by centrifugation. The pellet was directly lysed in a
modiﬁed lysis buffer (50mM HEPES pH 7.4, 250mM
NaCl, 1mM EDTA, 1% NP-40, 2mM Na3VO4, 50mM
NaF, 20mM b-glycerophosphate, 4 mM TSA, 1mM
PMSF, 1 protease inhibitor cocktail from Roche
(11697498001) containing TSA for inhibiting HDAC.
After rotating for 30min at 4C, the lysates were
centrifuged (15min, 13 000 r.p.m., 4C) and used for
Western blotting or were stored frozen.
Transiently transfected HEK293IL-1R cells
(Figures 1D and E, 3B, 5B and C) were harvested after
washing in cold PBS and collected by centrifugation. The
pellet was directly lysed in b-galactosidase lysis buffer as
described (36).
Mefs with a tamoxifen-inducible deletion of HDAC3
(Figure 2A) were harvested after washing in cold PBS
and collected by centrifugation. The pellet was directly
lysed in cell lysis buffer (10mM Tris pH 7.05, 30mM
Na4O7P2 10H2O, 50mM NaCl, 1% Triton X-100,
2mM Na3VO4, 50mM NaF, 20mM b-glycerophosphate,
1 mg/ml pepstatin, 10 mg/ml leupeptin, 1mM PMSF, 1 mM
microcystin), incubated for 15min on ice, and, after cen-
trifugation, the lysate was further used for Western
blotting.
For coimmunoprecipitation experiments (Figure 4B),
cells were harvested after washing in PBS and collected by
centrifugation. The pellet was directly lysed in cell lysis
buffer (50mM HEPES pH 7.4, 50mM NaCl, 1%
Tween20, 2.5mM EGTA, 1mM EDTA, 1mM NaF,
10mM b-glycerophosphate, 0.1mM Na3VO4, 1mM
PMSF, 1mM DTT, 1 protease inhibitor cocktail from
Roche) and incubated for 20min on ice. The DNA was
sheared by three sonication steps of 20 s, and lysates were
cleared by ultracentrifugation for 20min at 100.000g and
4C. HDAC3 was immunoprecipitated from 0.5mg
precleared cell extracts using 2 mg mouse monoclonal
anti-HDAC3 antibody (AbD Serotec) or 2 mg normal
mouse IgG (Santa Cruz) coupled for 2 h to 25 ml True
Blot anti-mouse Ig IP beads (eBioscience). After rotating
for 2 h at 4C, the supernatant was discarded, and the
beads were washed three times with high salt wash buffer
(50mM HEPES pH 7.4, 450mM NaCl, 1% Tween20,
2.5mM EGTA, 1mM EDTA, 1mM NaF, 10mM
b-glycerophosphate, 0.1mM Na3VO4, 1mM PMSF,
1mM DTT, 1 protease inhibitor cocktail from Roche).
The precipitated proteins were eluted by boiling in 2
Roti-Load for 10min before analyzing by western blotting.
NF-kB-p65-deﬁcient and reconstituted Mefs
(Figure 9A) were harvested after washing in cold
PBS and collected by centrifugation. The pellet was
directly lysed in cell lysis buffer (50mM HEPES pH 7.4,
50mM NaCl, 1% Tween20, 2.5mM EGTA, 1mM
EDTA, 1mM NaF, 10mM b-glycerophosphate, 0.1mM
Na3VO4, 1mM PMSF, 1mM DTT, 1 protease inhibitor
cocktail from Roche) and incubated for 20min on ice. The
DNA was sheared by three sonication steps of 20 s, and,
after ultracentrifugation for 20min at 100.000g at 4C, the
lysates were further used for western blotting.
For preparation of nuclear protein extracts
(Supplementary Figure S4), cells were harvested after
washing in cold PBS and collected by centrifugation.
The pellet was suspended in extraction buffer A (10mM
HEPES pH 7.9, 10mM KCl, 1.5mM MgCl2, 300 mM
Na3VO4, 20mM b-glycerophosphate, 10 mM E64,
5mM DTT, 2.5 mg/ml leupeptin, 1 mM pepstatin, 300 mM
PMSF, 1 mMmicrocystin), centrifuged (5min, 2000 r.p.m.,
4C) and resuspended again in extraction buffer A con-
taining NP-40 with a ﬁnal concentration of 0.1%. After
incubation on ice for 10min, samples were centrifuged
(5min, 13 000 r.p.m., 4C), and the supernatants (corres-
ponding to cytoplasmic extracts) were collected. Nuclear
extracts were prepared by resuspending pellets in extrac-
tion buffer B (20mM HEPES pH 7.9, 420mM NaCl,
1.5mM MgCl2, 200 mM EDTA, 300 mM Na3VO4,
20mM b-glycerophosphate, 10 mM E64, 5mM DTT,
2.5 mg/ml leupeptin, 1 mM pepstatin, 300 mM PMSF,
1 mM microcystin, 25% glycerol) followed by mixing, in-
cubation on ice for 30min and centrifugation (5min,
13 000 r.p.m., 4C). The supernatants correspond to
nuclear extracts.
Cytosolic and soluble nuclear fractions were prepared
as described (43) with the following modiﬁcations. Cells
were washed twice with ice-cold PBS and harvested by
centrifugation (500g, 5min, 4C). For separation of
soluble and insoluble nuclear fractions (Figure 6B),
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cells were lysed in lysis buffer 1 (20mM HEPES pH 8.0,
10mM KCl, 1mM MgCl2, 0.1% Triton X-100, 20%
glycerol, 50mM NaF, 1xRoche protease inhibitor mix,
1 mM microcystin, 1mM Na3VO4) for 10min on ice and
centrifuged for 1min at 2300g at 4C. The supernatant
(C, cytosol) was removed, and the pellet was lysed in
lysis buffer 2 (20mM HEPES pH 8.0, 2mM EDTA,
400mM NaCl, 0.1% Triton X-100, 20% Glycerol,
50mM NaF, 1xRoche protease inhibitor mix, 1 mM
microcystin, 1mM Na3VO4) for 20min on ice, vortexed
twice and centrifuged at 20 400g at 4C for 5min. The
supernatant (N1, soluble nuclear fraction) was removed,
and the pellet was lysed in buffer 3 (20mM Tris (pH
7.5), 2mM EDTA, 150mM NaCl, 1% SDS, 1% NP-40,
50mM NaF, 1xRoche protease inhibitor mix, 1mM
microcystin, 1mM Na3VO4). The DNA was sheared by
sonication for 20 s, and lysates were incubated for 50min
on ice, repeatedly vortexed and centrifuged at 20 400g at
A
B C
D E
Figure 1. Interference with HDAC3 inhibits IL-8 transcription. (A) HEK293IL-1R cells were stably transfected with an empty shRNA vector
(pS-Puro, black bars) or with a plasmid encoding a HDAC3-speciﬁc shRNA (pS-HDAC3, white bars) to generate shRNA-mediated HDAC3
knockdown cells. HDAC3 knockdown and control cells were treated for 3 h with IL-1 (10 ng/ml) or/and for 24 h with TSA (300 ng/ml) as indicated.
IL-8 mRNA expression was determined by RT-qPCR. Data represent the mean IL-8 expression±standard errors of the means (SEM) relative to the
unstimulated control (n=2). Black bars: pS-Puro, white bars: pS-HDAC3. The right part shows a control of the knockdown efﬁciency. Cell lysates
were tested by immunoblotting (IB) for the occurrence of HDAC3 and b-actin as a loading control. (B) HDAC3 knockdown (pS-HDAC3, white
bars) and control cells (pS-Puro, black bars) were stimulated for the indicated periods with IL-1 and analyzed for IL-8 mRNA expression as
described in (A). Data represent the mean IL-8 expression±SEM relative to the unstimulated control (n=2). (C) HEK293IL-1R cells were
pretreated for 24 h with increasing concentrations of the HDAC3 inhibitor apicidin and stimulated for 3 h with IL-1 as shown. RT-qPCR was
used to determine IL-8 mRNA expression, bars show the mean IL-8 expression±SEM relative to the unstimulated control (n=2). (D) HDAC3
knockdown (pS-HDAC3, white bars) and control cells (pS-Puro, black bars) were transiently transfected with an IL-8 promoter controlled luciferase
reporter gene and SV40-b-gal for normalization. Twenty-four hours later, cells were stimulated for 4 h with IL-1 or were left untreated as indicated.
Thereafter, cells were lysed, and luciferase and b-galactosidase activities were determined in cell extracts. Shown are the normalized mean luciferase
activities ± SEM from four independent experiments. (E) HEK293IL-1R cells were transiently transfected with an IL-8 promoter controlled
luciferase reporter gene as in (D). Twenty-four hours later, cells were treated for 24 h with 1 mg/ml apicidin and thereafter stimulated for 3 h with
IL-1 or were left untreated as indicated. Thereafter, cell extracts were prepared, and luciferase and b-galactosidase activities were determined. Shown
are the normalized mean luciferase activities ± SEM from two independent experiments.
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4C for 5min. The supernatant (N2, insoluble nuclear
fraction) was collected.
Immunoblotting
After electrophoresis on a denaturing polyacrylamide gel,
proteins were transferred to a polyvinylidene diﬂuoride
membrane (Roth) by semi-dry blotting. After blocking
with 5% bovine serum albumin or 5% dried milk in
Tris-buffered saline/0.05% Tween for 1 h, proteins were
visualized by sequential incubation with primary
antibodies for 12–24 h, washed in Tris-buffered saline/
0.05% Tween and incubated for 1 h with the peroxidase-
coupled secondary antibody. Proteins were detected by
using enhanced chemiluminescence systems from Pierce,
Millipore or GE Healthcare.
Analysis of p65 acetylation by Ni2+-NTA puriﬁcation
Denaturing puriﬁcation of p65 was used to visualize p65
acetylation (Figures 4A and 5A, Supplementary Figures
S8 and S9), which is readily lost in standard buffers. Cells
were harvested, and the washed cell pellet was lysed in 1ml
of lysis buffer A (6M guanidine-HCl, 0.1 M Na2HPO4/
NaH2PO4, 10mM imidazole, pH 8.0). The DNA was
sheared by one sonication step of 30 s, and lysates were
cleared by centrifugation for 15min at 15 000g. Also,
1.5mg of lysate proteins were incubated with 50 ml of
Ni2+-NTA agarose for 2 h at room temperature on a
rotating device. Beads were collected by centrifugation
(1min at 13 000g), washed twice in lysis buffer A, twice
in a buffer containing 1 volume of lysis buffer A and three
volumes of buffer TI (25mM Tris, 20mM imidazole,
pH 6.8), and twice with buffer TI alone. Bound proteins
were eluted by boiling for 10min at 95C in 150 ml 1
Roti-Load (Roth). Also, 200 mg of proteins from the
initial lysate (input) were precipitated by adding one
volume of trichloroacetic acid (TCA) (11%) at 4C. The
pellet was collected at 15 000g for 15min at 4C, washed
once with 200 ml ethanol (100%) (15 000g for 15min at
4C), air dried and resuspended in 150 ml of 1
Roti-Load (Roth) at 95C for 10min. Bound and
input protein samples were separated by 7.5% SDS-
PAGE including 4.5% glycerol and analyzed by western
blotting.
Figure 3. Overexpression of HDAC3 enhances mRNA expression of
inﬂammatory genes. (A) HEK293IL-1R cells were transiently trans-
fected to express wild-type HA-tagged p65 along with p300 and
HA-tagged HDAC3. Twenty-four hours later, cells were lysed, and
mRNA expression of IL-8 and CXCL2 was determined by RT-
qPCR. Shown is the mean -fold increase ± SEM relative to the
vector-transfected control from two independent experiments. (B) In
parallel, expression of HA-tagged p65 and HDAC3 was analyzed by
immunoblotting of lysates. One representative out of two experiments
is shown. The position of a molecular weight marker is indicated at
the left.
Figure 2. Deletion of the HDAC3 genes inhibits IL-1-triggered Cxcl2
transcription. (A) Immortalized murine embryonic ﬁbroblast (Mef) lines
were generated from mice harboring ﬂoxed Hdac3 alleles and the
tamoxifen-inducible Cre recombinase gene (33). These cells contain
a heterozygous ﬂoxed Hdac3 allele in the wild-type background
(Hdac3 ﬂ/+) or in the knockout background (Hdac3 ﬂ/) and become
thus heterozygous for Hdac3 or lack both Hdac3 alleles after
Cre-mediated deletion of the ﬂoxed gene. These cells were treated for
72 h with increasing concentrations of tamoxifen as shown and
analyzed for HDAC3 and b-actin expression by immunoblotting.
(B) The cells with the indicated genotypes were treated for 3 days
with 10 mM of tamoxifen and then stimulated for 0.5 h with IL-1 as
shown. RT-qPCR was used to quantify Cxcl2 mRNA expression.
Shown are the mean -fold changes compared with the untreated
Hdac3 ﬂ/+ control line, error bars represent SEM from three different
experiments performed in duplicates.
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Microarray-based mRNA expression analysis and
bioinformatic analyses
Human or murine cell lines were transfected and treated as
speciﬁed in the text. Total RNA was extracted using the
Nucleo Spin RNA II-Kit from Macherey & Nagel.
The ‘Whole Human Genome Oligo Microarray’
(G4112F, ID 014850, Agilent Technologies) used for the
experiments shown in Figures 7 and 8 contains 45 015
oligonucleotide probes covering the entire human tran-
scriptome. Human samples were processed and ﬁnally
hybridized according to the two-color mode. The ‘Whole
Mouse Genome Oligo Microarray V2’ (G4846A, ID
026655, Agilent Technologies; Santa Clara, California,
USA) used in Figure 9C and Supplementary Figures S6,
S7, S11 contains 44 397 oligonucleotide probes covering
the entire murine transcriptome. Murine samples were
processed and hybridized in single-color mode. Synthesis
of Cy3- or Cy5-labeled cRNA was performed with the
‘Quick Amp Labeling kit, two color’ (#5190-0444,
Agilent Technologies) or one color’ (#5190-0442), accord-
ing to the manufacturer’s recommendations. cRNA frag-
mentation, hybridization and washing steps were also
carried out exactly as recommended in ‘Two-Color
Microarray-Based Gene Expression Analysis Protocol
V5.7’ (see http://www.agilent.com for details), except
Figure 4. HDAC3 binds to and deacetylates p65 at lysines K310, K314 and K315. (A) HEK293IL-1R cells were transiently transfected to express
wild-type His-tagged p65 along with YFP-tagged CBP and HA-tagged HDAC3. Cells were lysed under denaturing conditions, proteins were
precipitated by TCA, redissolved and equal amounts were analyzed for general acetylation of p65 with a pan-acetyl-lysine-speciﬁc antibody or
with antibodies speciﬁc for acetylated p65 K310, K314 and K315 as shown. Expression of HDAC3 and YFP-CBP was validated as indicated and
equal loading of lanes was conﬁrmed by anti-b-actin antibodies. The position of a molecular weight marker is indicated at the Left
(B) HEK293IL-1R cells were transfected to express the indicated combinations of HA-tagged HDAC3 and HA-tagged p65 variants. Following
lysis of cells, extracts were used for immunoprecipitation (IP) of the HDAC3 protein, and co-precipitating proteins were revealed with antibodies
recognizing p65 NF-kB. IPs with murine (m) IgG were performed in parallel to control the speciﬁcity of the interactions. Arrows mark different
HDAC3 isoforms.
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that 3–4mg of each labeled cRNA sample were used for
hybridization. Slides were scanned on the Agilent Micro
Array Scanner G2565CA (pixel resolution 5 mm, bit depth
20). Data extraction was performed with the ‘Feature
Extraction Software V10.7.3.1’ by using the recommended
default extraction protocol ﬁles GE2_107_Sep09.xml
(two-color) or GE1_107_Sep09.xml (one-color),
respectively.
Data normalization
Microarray raw data extracted by the Feature Extraction
software were normalized and analyzed in Genespring GX
software, version 11.5.1 (Agilent Technologies). Expression
values were log2 transformed, normalized to 75th percentile
of each array and inter array median centered according to
the standard procedure in Genespring GX.
Figure 5. Acetylation mimicking mutants of p65 suppress IL-8 gene expression. (A) HEK293T cells were transfected with expression plasmids
encoding His-tagged p65 wild-type or a mutated version thereof where K122, K123, K310, K314 and K315 (K5R) were mutated to arginines
along with 0.75 and 1.5 mg of a plasmid for YFP-tagged CBP. One fraction of cells was lysed under denaturing conditions to analyze acetylation of
p65 with the indicated acetyl-lysine-speciﬁc antibodies. The lower part shows the input control ensuring adequate protein expression.
(B) HEK293IL-1R cells were transfected with the indicated p65 wild-type and acetylation-deﬁcient expression vectors plus the IL-8 promoter
reporter gene construct and the pSV40-b-galactosidase construct. Twenty-four hours later, cells were lysed, and luciferase reporter gene activity
was determined and normalized for b-galactosidase activity. Normalized mean luciferase activities ± SEM relative to the vector control from ﬁve
independent experiments (upper graph) are shown. In parallel transfections, cells were transfected to express HA-tagged p65 wild-type or the
indicated acetylation-mimicking mutants thereof. The next day, cells were lysed, and one portion of the lysates was analyzed for mRNA expression
of the endogenous IL-8 gene by RT-qPCR. Bars show mean ± SEM from two independent experiments (lower graph). Another portion was tested
by immunoblotting for correct expression of p65. The positions of a molecular weight marker are shown, and the HA-p65 migrates slightly slower
than the endogenous p65. (C) HEK293IL-1R cells were transfected with additional p65 mutants and analyzed exactly as described in (B). IL-8
promoter activity represents the mean ± SEM from three independent experiments normalized for protein concentration (upper graph). IL-8 mRNA
expression represents the mean fold change ± SEM relative to the vector control from three independent experiments (lower graph). All samples
were analyzed for comparable expression of the constructs in parallel, one representative immunoblot is shown.
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Identiﬁcation of TSA- and IL-1-regulated genes in
HDAC3 knockdown cells
In all, 29 421 probes with EntrezGeneID showed hybrid-
ization signals more than the 20% percentile. Of these,
24 755 probes corresponding to 16 412 genes were meas-
urable in at least 4 of the 16 microarray hybridizations.
This data set was used for further analyses (Figures 7 and
8). The pS-Puro and pS-HDAC3 data sets were ﬁltered
separately for genes showing differential regulation by
IL-1 by at least 1.5-fold, revealing a total of 75 probes
corresponding to 70 genes with consistent regulation.
Expression values for these genes above background had
to be measurable in at least the stimulated condition (for
Figure 6. Suppression of HDAC3 affects p65 recruitment and phosphorylation of RNA polymerase II at the IL-8 promoter. (A) Human KB cells
were stably transfected with an empty shRNA vector (pS-Puro, gray bars) or with a plasmid encoding a HDAC3-speciﬁc shRNA (pS-HDAC3, white
bars) to generate shRNA-mediated HDAC3 knockdown cells. HDAC3 knockdown and control cells were treated for 1 h with IL-1 or were left
untreated. IL-8 mRNA expression was determined by RT-qPCR. Data represent the mean IL-8 expression±SEM relative to the unstimulated
control (n=2). (B) The same cells as in (A) were stimulated for the indicated times with IL-1 or were left untreated. Cytosolic (C), soluble nuclear
(N1) and insoluble nuclear (N2) extracts were prepared and analyzed for the presence of the indicated proteins by immunoblotting. The amounts of
p65 and HDAC3 in the nuclear fractions were quantitated, and expression levels are shown relative to those of untreated cells. Shown is one out of
two experiments. (C) The same cells as in (A) were stimulated for 1 h with IL-1 or were left untreated. Chromatin immunoprecipitation was
performed using the indicated antibodies and imunoprecipitated DNA was quantiﬁed by qPCR using primers spanning the IL-8 promoter/
enhancer region and a non-regulatory upstream region as a negative control. Relative enrichment of immunoprecipitated DNA is shown as per-
centage of input DNA. Shown are mean values ± SEM from two independent experiments performed in duplicates.
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Figure 7. HDAC3 is a global regulator of the transcriptional IL-1 response. HEK293IL-1R cells stably transfected with pSuper-Puro (pS-Puro) or
with pSuper-Puro encoding a shRNA-directed against HDAC3 (pS-HDAC3), as shown in Figure 1A, were treated for 24 h with vehicle (EtOH,
0.03%) or with TSA (300 ng/ml). These cells remained unstimulated or were treated for 3 h with IL-1. Total RNA was isolated from two independent
experimental groups (exp. 1 and exp. 2), labeled cRNA was prepared and was hybridized to whole genome Agilent microarrays. (A) Normalized
ﬂuorescence intensity values were used to calculate the total number of genes, which were regulated in the same direction by IL-1 by at least 1.5-fold
in both independent experiments compared with the EtOH-treated vehicle control. Data analysis revealed 70 IL-1 regulated genes. Of those, only
seven genes were still inducible in the absence of HDAC3, as illustrated by the depicted Venn diagram. (B) The gene set identiﬁed in (A) was
clustered hierarchically, and ratio values are shown as a colored heatmap. Vertical color-coded bars indicate groups of genes contained in the Venn
diagram shown in (A). Brown vertical bars indicate all genes with at least 2-fold regulation by IL-1. The entire data set is shown in Supplementary
Table S2.
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Figure 8. Comparison with the pan-HDAC inhibitor TSA reveals differential and restricted effects of HDAC3 and IL-1 on speciﬁc sets of genes.
(A) The microarray data set from the experiments described in Figure 7 was used to calculate the total number of genes, which were regulated in the
same direction by TSA by at least 2-fold in both independent experiments compared with the EtOH-treated vehicle control. This revealed 4241 genes
whose overlap between control cells and HDAC3 knockdown cells is illustrated by the depicted Venn diagram. (B) The TSA-regulated set of genes
identiﬁed in (A) was additionally ﬁltered for HDAC3-dependent genes based on a ratio of pS-HDAC3/pS-Puro (lanes 13, 14) of at least 1.5-fold
in two independent experiments revealing 130 genes. Similarly, the set was ﬁltered for genes, which were regulated by IL-1 by at least 1.5-fold
revealing 24 genes. Depicted are color-coded ratio values of all 154 genes, which were calculated by dividing ﬂuorescence intensity measurements of
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Figure 8. Continued.
vehicle-treated cells or IL-1 or TSA treatments by those obtained for the vehicle control situation of either control cells (lanes 1, 2) or HDAC3
knockdown cells (lanes 7, 8). In lane 13 and 14, ratios were calculated by dividing pS-HDAC3 by pS-Puro values. Both data were sorted according to
the mean regulation by TSA in descending order. Vertical green and blue bars indicate HDAC3- and IL-1-dependent genes as described for (A). The
ratio values from both independent experiments are shown side by side (exp. 1, 2). Solid black arrows indicate examples of genes, which are elevated
by both, TSA and HDAC3 knockdown, whereas dotted black arrows indicate genes with adverse regulation by TSA or HDAC3 knockdown,
respectively. (C) Depicted are the color-coded ratio values for the 75 most strongly upregulated genes (red colors) or 75 most strongly downregulated
genes (blue colors) in response to TSA from the same data set.
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upregulated genes) or in the unstimulated condition (for
downregulated genes). Differential expression of genes in
this ﬁnal set was signiﬁcant (P 0.01) in at least one out of
four comparisons according to feature extraction software
algorithms.
In all, 5045 probes showed differential hybridization
signals of at least 2-fold in TSA stimulated pS-Puro or
pS-HDAC3 cells. This data set was ﬁltered for consistent
regulation resulting in 4241 genes: The probes were
separated into three subsets: (i) TSA-regulated, HDAC3
knockdown dependent, not IL-1-regulated; (ii) TSA-
regulated, HDAC3 knockdown independent, IL-
1-regulated; and (iii) TSA-regulated, HDAC3 knockdown
independent, not IL-1-regulated. In case of multiple
probes per gene in the same subset, only one probe was
selected for further analysis. Probe values were removed
from other subsets, if probe values for the same gene
occurred in intersections of data sets (i–iii). Probes
measuring identical genes but having been assigned to dif-
ferent subsets were removed from the data sets.
Identiﬁcation of IL-1-regulated genes in
HDAC3-deﬁcient cells
In all, 25 415 probes with EntrezGeneID corresponding to
15 766 annotated transcripts showed hybridization signals
more than the 20% percentile, no ﬂags and were measur-
able in at least four out of eight microarray hybridizations
(Supplementary Figure S6). This data set was ﬁltered
for genes showing differential regulation by IL-1 by at
least 1.5-fold, revealing a total of 112 probes correspond-
ing to 95 genes with consistent regulation. In all, 593
probes corresponding to 490 genes were regulated by tam-
oxifen treatment by at least 2-fold in both experiments.
Seven of these genes (1.4%) were also regulated by IL-1.
Identiﬁcation of p65 K4Q- or p65 K5Q-dependent genes
In all, 19 850 probes with EntrezGeneID corresponding to
14 761 annotated transcripts showed normalized hybrid-
ization signals more than the 20% percentile and were
measurable in at least 8 out of 24 hybridizations
(Figure 9C and D and Supplementary Figure S7).
This set of data was ﬁltered for genes showing consistent
2-fold regulation in both experiments based on the ratio
p65 wild-type/p65/ (416 probes, 341 genes) or IL-1 +
p65 wild-type/p65/ (908 probes, 836 genes). Only
unﬂagged probes and probes with hybridization signals
above 2-fold background signals (>110 ﬂuorescence inten-
sity units) in p65 wild-type or p65 wild-type+IL-1
samples in at least one experiment were included to
identify an overlapping set of 975 probes corresponding
to 851 IL-1-regulated or p65 target genes. These were
further ﬁltered to identify 135 K4Q-dependent or
109 K5Q-dependent genes based on 2-fold ratios (K4Q
or K5Q/p65 wild type) and p65 K4Q/p65 K4R 2.0 or
p65 K5Q/p65 K5R 2.0.
Clustering and graphical visualization of microarray data
Log2-transformed ratio values were analyzed by hierarch-
ical cluster analysis using MeV MultiExperimentViewer,
version 4.6.2, 2011, (www.tm4.org) with cluster settings
‘average linkage’ as linkage method and ‘Manhattan
distance’ for distance measure (44).
Statistics and quantiﬁcation
Mean and standard errors of the means were calculated
using Sigma Plot, version 11.0. Bands detected by im-
munoblotting were quantiﬁed using ImageJ (http://
rsbweb.nih.gov/ij/).
RESULTS
HDAC3 is required for IL-1 triggered expression of
the human IL-8 gene
We previously found that HDAC3 associated with c-Jun
and p65 NF-kB at IL-1-regulated target genes (45). To
further unravel a functional role for HDAC3 in cytokine
signaling, we established stable HEK293IL-1R cell lines
with a partial shRNA-mediated downregulation of
HDAC3 (Figure 1A). These cells and vector controls
were stimulated with IL-1 either alone or in combination
with TSA, a fungal antibiotic, which inhibits class I and II
HDACs roughly to the same extent (46,47). Analysis of
IL-8 expression by RT-qPCR showed that IL-1-triggered
IL-8 mRNA was further stimulated by TSA in a synergis-
tic manner (Figure 1A), which is in accordance with the
general role of HDACs as negative regulators of
acetylation-dependent chromatin relaxation (48). In
marked contrast, knockdown of endogenous HDAC3 by
shRNA strongly inhibited IL-1-induced IL-8 expression,
indicating an important role of HDAC3 for productive
IL-8 transcription (Figure 1A). To further investigate
this ﬁnding in a time-resolving manner, control and
HDAC3 knockdown cells were stimulated for various
periods with IL-1, followed by analysis of IL-8 mRNA
expression by quantitative RT-qPCR (Figure 1B). These
experiments revealed a critical role of HDAC3 for gene
expression during the induction and peak phases of the
IL-8 response.
As some HDAC3-dependent effects are independent
from its enzymatic function as a deacetylase (49), it
was then important to measure IL-1-induced IL-8 tran-
scription in the presence of the inhibitory compound
apicidin, which selectively inhibits HDAC3 and also
with a minor efﬁciency HDAC2 (50,51). Increasing con-
centrations of apicidin blocked induced IL-8 mRNA ex-
pression in a dose-dependent manner in HEK293IL-1R
cells (Figure 1C) and also in the tumor cell lines KB and
A549 (Supplementary Figure S1), thus revealing the im-
portance of the enzymatic function of HDAC3 for its
stimulatory function on transcriptional regulation of
gene expression.
As HDACs can regulate gene expression by global
effects on chromatin compaction (52), it was interesting
to investigate whether HDAC3 inhibition also affects gene
expression from an IL-8 promoter that is not embedded
into its native chromatin context. To address this question,
HEK293IL-1R cells were transfected with a luciferase
plasmid under the control of an IL-8 promoter. IL-1 trig-
gered luciferase expression was diminished in HDAC3
knockdown cells (Figure 1D) or in the presence of
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apicidin (Figure 1E), showing that HDAC3-mediated
effects directly control transcriptional activation of the
IL-8 promoter in a chromatin-independent manner.
HDAC3 is required for IL-1 triggered expression of
the murine Cxcl2 gene
To investigate the contribution of HDAC3 on inﬂamma-
tory gene expression by an independent experimental
approach, we performed further experiments with
immortalized Mef lines generated from mice harboring
ﬂoxed Hdac3 alleles, which were crossed with mice con-
taining a tamoxifen-inducible Cre recombinase gene (33).
These cells contain a heterozygous-ﬂoxed Hdac3 allele in
the wild-type background (Hdac3 ﬂ/+) or in the knockout
background (Hdac3 ﬂ/) and thus become heterozygous
for Hdac3 or lack both Hdac3 alleles after Cre-mediated
deletion of the ﬂoxed gene. To determine the optimal dose
of tamoxifen for efﬁcient HDAC3 knockout, cells were
treated for 3 days with increasing concentrations of
tamoxifen and analyzed for HDAC3 protein levels by im-
munoblotting. These experiments revealed strong reduc-
tion of HDAC3 levels at a concentration of 10 mM
tamoxifen (Figure 2A). Ablation of HDAC3 under these
conditions also resulted in reduced cell viability (data not
shown), which is in line with its reported necessity for
maintenance of genome stability and S phase progression
(30,33). To study a role of HDAC3 in this genetically
altered system after the induction of gene deletion by tam-
oxifen, these cells remained untreated or were stimulated
by IL-1, followed by analysis of Cxcl2 transcription by
RT-qPCR (Figure 2B). Loss of one Hdac3 allele slightly
reduced IL-1-triggered Cxcl2 expression, whereas deletion
of both alleles strongly impaired the transcriptional
response (Figure 2B). Control experiments ensured that
these inhibitory effects are not due to any tamoxifen-
mediated effects, as in two other Mef lines Cxcl2 expres-
sion was not suppressed but rather weakly induced on
tamoxifen treatment (Supplementary Figure S2).
Moreover, four shRNA oligonucleotides directed against
murine HDAC3 also suppressed IL-1-inducible Cxcl2 ex-
pression (Supplementary Figure S3). Together with the
experiments involving human cells (Figure 1 and
Supplementary Figure S1), these data provide several in-
dependent lines of evidence for a positive role of HDAC3
for IL-1-mediated gene expression.
HDAC3-mediated p65 deacetylation augments NF-iB
transcriptional activity
The pro-transcriptional activity of HDAC3 raises the
question for its molecular target(s) that mediate this
effect. The expression of IL-8 (36) and Cxcl2 (53)
depend on NF-kB and HDAC3 has been reported to
interact with NF-kB p65 (9). Ectopic expression of p65
activated expression of endogenous IL-8 and Cxcl2
genes (Figure 3). Moreover, co-expression of HDAC3
enhanced p65-mediated expression of both genes, an
effect which was pronounced in the presence of p300
(Figure 3A and B). To identify the molecular basis for
this activating effect of HDAC3, we tested whether
HDAC3 can lead to the deacetylation of p65. Cells were
transfected to express His-tagged p65 and CBP along with
an expression vector for HDAC3 and were lysed under
denaturing conditions to prevent removal of acetyl
groups after cell lysis, and His-tagged p65 was enriched
on Ni-NTA matrices. The acetylation status of p65 was
analyzed by immunoblotting with pan-acetyl-lysine-
speciﬁc antibodies or with three different antibodies
recognizing site-speciﬁc acetylation at lysines 310, 314
and 315 (Figure 4A). These experiments showed that
CBP-induced acetylation of p65 was largely lost in the
presence of HDAC3, as revealed by the use of the
pan-acetylation antibody and also by the site-speciﬁc
antibodies recognizing p65 acetylated at lysines 310, 314
or 315. These data revealed HDAC3 as a major and
speciﬁc p65 deacetylase.
Given the reported interaction between p65 and
HDAC3 (9), we designed experiments to analyze the
possible regulation of this association. As substrate
binding of HATs can be regulated by binding to
acetylated lysine moieties via bromodomains (21), we
compared binding of HDAC3 between wild-type p65
and mutants thereof, which were changed in four (K122,
K123, K314, K315) or all ﬁve (K122, K123, K310, K314,
K315) known acetylated lysines either in a lysine acetyl-
ation inactivating way to arginine (p65 K4R, p65 K5R) or
in a lysine acetylation mimicking way to glutamine (p65
K4Q, p65 K5Q). Coimmunoprecipitation experiments
conﬁrmed the HDAC3/p65 interaction and showed
similar HDAC3 binding of all p65 mutants (Figure 4B).
The slightly impaired binding of the p65 K4Q or p65 K5Q
mutants is attributable to a lower general expression of
HDAC3 in the presence of p65 K4Q or p65 K5Q, which
might be due to inhibitory effects on cryptic NF-kB
binding sites in the vector sequences driving the expression
of the HDAC3 cDNA. To investigate the role of p65
acetylation in more detail, we generated a p65 mutant
that is widely refractory to acetylation. As the p65 K4R
mutant still contains the acetylated lysine 310 (10), we
used a mutant where also this lysine was mutated to
arginine (p65 K5R). Although expression of CBP trig-
gered acetylation of wild-type p65, the p65 K5R mutant
was completely devoid of any acetylation (Figure 5A),
thus excluding the existence of additional major acetyl-
ation sites in p65. This experiment, therefore, revealed
the suitability of K5 mutants for further experiments.
In a next step, transcriptional activation mediated
by p65 wild-type was compared with that of various p65
K/Q mutants mimicking acetylation at one or several
lysines. Cells were transfected to express similar amounts
of these different p65 variants (Figure 5B), followed by the
analysis of IL-8 transcription by reporter gene assays
(Figure 5B, upper graph) or IL-8 mRNA expression by
RT-qPCR (Figure 5B, lower graph). Although wild-type
p65 strongly activated IL-8 mRNA expression and tran-
scription, the p65 K310Q mutant was slightly more active
in activating mRNA expression, which is in line with pub-
lished data on a positive role of acetylation at K310 for
NF-kB activity (10). In striking contrast, the p65 K4Q and
p65 K5Q mutants had lost their transactivating capacity
to induce IL-8 mRNA expression and transcription
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(Figure 5B), although in vitro their DNA-binding and
dimerization capacities are known to be fully intact (15).
To delineate the role of acetylation-mimicking muta-
tions of K122, K123, K314 and K315 in more detail,
these residues were mutated individually or in tandem
combinations. Analysis of IL-8 transcription and mRNA
expression revealed a strong inhibitory effect of the
K122Q mutation, whereas mutations of K123, K314 and
K315 were less inhibitory (Figure 5C).
HDAC3 is required for IL-1-induced recruitment of
p65 NF-iB and RNA polymerase II phosphorylation at
the IL-8 promoter
Acetylation of K122 and K123 has been previously
implicated in reduction of p65 DNA-binding in vitro (9).
To assess the effects of HDAC3 knockdown on NF-kB
nuclear translocation, overall DNA-binding and recruit-
ment to the endogenous IL-8 gene, we used KB cells that
we found previously well suited for chromatin
immunoprecipitation (ChIP) analysis of IL-1-induced
genes (36). Similar to HEK293IL-1R cells, HDAC3
knockdown in KB cells diminished IL-1-induced IL-8 ex-
pression (Figure 6A). To test the impact of HDAC3 on
IL-1-triggered translocation of p65 to the nucleus, cells
were stimulated with this proinﬂammatory cytokine and
fractionated. Western blot experiments showed that
knockdown of HDAC3 did not affect IL-1-induced accu-
mulation of p65 in the soluble nuclear fraction, whereas
the amount of p65 in the insoluble nuclear fraction was
reduced by 50% (Figure 6B). This result suggests that
HDAC3 does not modulate cytosolic pathways mediating
p65 nuclear translocation but rather is required for stable
association of p65 with chromatin. To investigate this pos-
sibility further, ChIP were performed, which showed
reduced recruitment of p65 NF-kB to the IL-8 promoter
(Figure 6C). Further ChIP experiments revealed that
downregulation of HDAC3 also resulted in strongly
reduced amounts of RNA polymerase II phosphorylated
at serine 5 at the IL-8 promoter, which is in line with
its negative effects on IL-8 mRNA synthesis. Control
experiments showed no association of p65 binding and
RNA polymerase II phosphorylation at a region 940 bp
upstream of the IL-8 promoter, demonstrating the speci-
ﬁcity of the ChIP analyses (Figure 6C). Compared with
this upstream region, the IL-8 promoter displayed a lower
density of histone H3 and higher acetylation of histone H3
at lysine 9, which suits the needs for a more open chro-
matin structure of this rapidly inducible gene (Figure 6C).
HDAC3 knockdown cells showed no changes of histone
H3 loading and acetylation (Figure 6C) arguing for
speciﬁc effects of HDAC3 on transcriptional activators
of IL-8 rather than on more general changes of the local
chromatin structure. These effects seem to be independent
from stable association of HDAC3 with chromatin, as we
were not able to detect stable HDAC3 recruitment to the
IL-8 locus by ChIP (Figure 6C) or by ChIP followed by
deep sequencing of DNA (ChIP-seq) (data not shown)
with the antibodies available to us.
These data indicate that acetylation of at least one
residue of lysines 122, 123, 314 and 315 accounts for
inhibition of p65 activity for IL-8 expression and suggest
that removal of these acetyl groups by HDAC3 is a neces-
sary positive regulatory step in the nucleus, which facili-
tates contact of p65 with speciﬁc DNA elements for
activating p65-driven gene transcription.
A general role of HDAC3 for the induction of the
IL-1-gene response
Previous studies have shown that the effect of NF-kB p65
modiﬁcations occur in a highly gene-speciﬁc fashion
(15,54). It was therefore interesting to investigate the
role of HDAC3 in IL-1-induced gene expression at a
genome-wide level. HDAC3 knockdown cells and vector
controls were stimulated with IL-1 and compared with
cells in which global acetylation was boosted on TSA-
mediated inhibition of all major HDACs. Successful
TSA treatment was conﬁrmed by TSA-induced histone
H3 acetylation (Supplementary Figure S4).
Gene expression was measured by two independent high
density microarray experiments, followed by data ﬁltering
for genes regulated consistently in the same direction.
These experiments allowed the identiﬁcation of 70 genes
regulated by IL-1 by at least 1.5-fold in two independent
experiments (Figure 7A). Only seven genes were still indu-
cible in HDAC3 knockdown cells, showing that HDAC3
is required for the majority of all IL-1-induced genes in
HEK293IL-1R stable cell lines (Figure 7A).
A hierarchical cluster analysis of the groups of genes
identiﬁed in Figure 7A visualizes the individual relevance
of HDAC3 for virtually all IL-1-inducible genes
(Figure 7B, yellow and green bars). These ﬁndings were
conﬁrmed in a time-resolving fashion by RT-qPCR for the
selected target genes CXCL1, CXCL2, CXCL3 and
NFKBIA (Supplementary Figure S5).
To support this conclusion by an independent experi-
mental approach, IL-1-induced gene expression was
compared between control Mefs and Mefs treated with
tamoxifen to obtain Cre-inducible ablation of the Hdac3
gene. As shown in Supplementary Figure S6A, we found
95 genes that were induced by IL-1 by at least 1.5-fold
in two independent experiments. The expression of
40 of them was suppressed by at least 2-fold after
tamoxifen-induced deletion of Hdac3. Tamoxifen itself
had weak inducing, but no inhibitory, effects on several
of these genes (Supplementary Figure S6B). Although 490
genes were regulated at least 2-fold by tamoxifen in both
experiments, only seven genes (1.4%) were inducible by
IL-1 (Supplementary Figure S6B). In summary, these
data show that the broad and co-stimulatory role of
HDAC3 for the IL-1-triggered transcriptional program
is not restricted to human cells and can also be found
in mice.
Comparison with the pan-HDAC inhibitor TSA reveals
differential and restricted effects of HDAC3 on
speciﬁc sets of genes
In addition, we interrogated the entire data set obtained
for HEK293IL-R cells for genes whose expression
depends on TSA-sensitive HDACs as compared with
HDAC3 alone. Because the group of TSA-regulated
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genes was very large, we initially used a 2-fold cut-off for
identifying 2983 TSA-regulated genes in control cells and
3755 TSA-regulated genes in cells depleted for HDAC3
(Figure 8A). Of those, 2497 genes were regulated by
TSA in both cell lines, which correspond to 83.71% of
all genes from control cells and 66.5% of all genes from
HDAC3 knockdown cells, revealing that transcriptome-
wide TSA effects are largely independent from the
HDAC3 expression level (Figure 8A). This interpretation
was corroborated by visualizing ratios of expression for
individual genes (Figure 8B). Using an additional 1.5-fold
cut-off, we identiﬁed a group of 130 TSA-sensitive genes
whose expression was also altered in HDAC3 knockdown
cells (Figure 8B, green bar). Of these, 68 were up- and 62
were downregulated constitutively in HDAC3 knockdown
cells compared with control cells, indicating that their con-
stitutive expression levels are modulated by HDAC3
(Figure 8B, green bar, lanes 13, 14). Some genes were
elevated by both, TSA or HDAC3 knockdown (e.g.
CTGF, CYR61, C2lorf88, LOC100287487, VCX, SOX3),
suggesting that their repression is under control of
HDAC3. Importantly, in several cases, genes were
regulated in the opposite direction by TSA treatment or
HDAC3 knockdown (e.g. CGA, HSPB3, INA, PIK3R3,
NAPI2, SOX11, PRAMEF3, SPARC), indicating that
HDAC3 plays a highly distinct role in their regulation
(Figure 8B).
This interpretation is in line with the result that the
overall induction or repression pattern of these 130
TSA-regulated genes was almost identical between
control and HDCA3 knockdown cells (Figure 8B, green
bar, compare lanes 5, 6 with lanes 11, 12) adding further
evidence for a highly selective role of HDAC3 in gene
expression. Moreover, as shown by the ratio values
indicated by the blue vertical bar, we also found 24
TSA-sensitive genes, which were also inducible by IL-1
(Figure 8B, blue bar). Although their expression was sup-
pressed by HDAC3 knockdown (Figure 8B, blue bar,
compare lanes 3, 4 with lanes 9, 10), their induction
by TSA was independent of HDAC3 (Figure 8B, green
bar, compare lanes 5, 6 with lanes 11, 12). Hence, the
data shown in Figure 8A and B suggest that only a
small fraction of TSA-regulated genes is controlled by
HDAC3.
Further support for this interpretation comes from the
analysis of the 150 most strongly up- or downregulated
TSA-sensitive genes. These highly regulated genes were
neither affected by HDAC3 knockdown nor by IL-1
(Figure 8C). Therefore, the top-ranking group of genes
regulated by TSA-sensitive HDACs is clearly distinct
from the smaller set of genes, which is regulated by IL-1
and HDAC3.
In conclusion, HDAC3 knockdown does not have a
general repressive or inducing effect on the transcriptome
per se and has little effect on global changes of gene ex-
pression compared with genome-wide-induced changes of
chromatin structure using pharmacological blockade of
HDACs. Our data also show that HDAC3 rather serves
as a co-activator for the majority of IL-1-induced genes
and thus identify it as a IL-1-speciﬁc nuclear signal inte-
gration node.
Acetylation of p65 down-regulates IL-1-target genes
We then investigated whether the stimulatory effects
of HDAC3 on gene expression is associated with its
ability to control the acetylation status of p65 NF-kB.
P65-deﬁcient Mefs stably reconstituted to express compar-
able amounts of wild-type, acetylation-deﬁcient (K/R)
or acetylation-mimicking p65 (K/Q) (Figure 9A) were
Figure 9. Speciﬁc inhibitory effects of p65 NF-kB acetylation-
mimicking mutants on IL-1-induced gene expression. (A) NF-kB
p65-deﬁcient Mefs (p65/) were reconstituted to express p65 NF-kB
wild-type (HA-p65) and its mutant forms as described in (15). A rep-
resentative western blot ensuring expression of comparable amounts of
p65 proteins is shown. (B) Mefs were stimulated for various periods
with IL-1 as indicated. Expression of Cxcl2 was analyzed by RT-qPCR.
Relative changes of mRNA expression compared with untreated cells
reconstituted with p65 NF-kB wild-type were calculated. Shown are the
relative mean values ± SEM from three independent experiments
compared with cells reconstituted with wild-type p65 (set as 1).
(C and D) Two RNA preparations from experiments performed as
described in (B) were used to prepare cRNA and to hybridize whole
genome Agilent microarrays. A set of 851 p65-dependent or
IL-1-induced genes was extracted based on 2-fold regulation in both
experiments. This set was further ﬁltered for genes affected by p65 K4Q
or p65 K5Q. Color-coded ratio values for the top-ranking genes of
these two subsets are shown. The entire sets of data are shown in
Supplementary Figure S7A and B. Gray colors indicate genes with
low hybridization signals on the microarrays. (C) Expression values
were used to identify 851 genes, which were regulated by IL-1 (ratio
IL-1 p65 wild-type/p65/) or are dependent on p65 NF-kB (ratio p65
wild-type/p65/). These genes are sorted according to mean regulation
by IL-1 in descending order and are indicated by the green vertical bar.
Genes regulated by IL-1 and suppressed by p65 K4Q (blue vertical
bars) or by p65 K5Q (brown vertical bars) were identiﬁed by ratio
values of p65 wild-type+IL-1/p65 K4Q+IL-1 or p65
K5Q+IL-1 2.0. (D) Expression values were used to identify 167
genes, which were dependent on p65 NF-kB (ratio p65 wild-type/
p65/) and regulated by p65 K4Q (yellow vertical bars) or by p65
K5Q (purple vertical bars) based on the ratio p65 K4Q or p65 K5Q/
p65 wild-type followed by p65 K4Q/p65 K4R and by p65 K5Q/p65
K5R. These genes are sorted according to mean regulation by p65 K4Q
in descending order.
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stimulated with IL-1 and analyzed for transcription of the
endogenous Cxcl2 gene by RT-qPCR. These results
revealed a p65-dependent robust activation of gene
expression and slightly elevated basal Cxcl2 expression
in cells expressing acetylation-deﬁcient p65 proteins
(Figure 9B). However, the p65 K4Q and K5Q mutants
had lost their ability to induce Cxcl2 expression in
response to IL-1 at all time points tested (Figure 9B). In
line with the results of transiently transfected human cells
(Figure 5), the acetylation-mimicking mutant K310Q was
not inhibitory, suggesting that acetylation at, at least, one
residue of K122, 123, 314 and 315 is mediating the inhibi-
tory effect (Figure 9B).
We also tested the effects of reconstituted p65K4Qor p65
K5Qmutants on the entire IL-1 response by performing 24
high density microarrays from two independent series of
experiments. We ﬁltered these data sets using 2-fold cut-
offs for p65 NF-kB-dependent and for IL-1-regulated
genes. In this group of 851 genes, the majority of IL-1-
induced genes was suppressed by the p65 K4Q or K5Q
mutants, suggesting that acetylation of p65 is a general
negative regulator of inﬂammatory gene expression
programs (Figure 9C). Of note, the K4R and K5R
mutants reverted to a large extent the K4Q or K5Q effects
arguing that these mutations inactivate the acetylation
phenotype (Figure 9C).
Figure 9. Continued.
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We also used the same data set to explore whether the
p65 K4Q or K5Q mutants were completely devoid of
activating genes. Interestingly, in unstimulated cells, we
found that p65 K4Q or p65 K5Q upregulated 77 genes
and repressed 56 genes. As shown in Figure 9D and
Supplementary Figure S7, a large part of these genes was
repressed in p65-deﬁcient cells and re-expressed
by reconstituting p65 wild-type, proving that they are
bona ﬁde p65 target genes. In most cases, K-Q and K-R
mutants had opposite effects on gene expression (Figure 9C
and D). These data support the conclusion that
acetylation-mimicking confers gene-speciﬁc properties of
p65. Moreover, such mutants had lost their ability to
trigger IL-1-dependent gene expression, thus corroborating
the concept that inhibitory p65 acetylations need to be
relieved by HDAC3 to activate cytokine-responsive genes.
Discussion
In this study, we provide several lines of evidence that
besides its well-deﬁned role as catalytic subunit of
co-repressor complexes, HDAC3 can also function as a
co-activator in inﬂammatory signaling pathways.
Our data further suggest that a substantial portion of
the co-activating property of HDAC3 is mediated by the
removal of inhibitory acetyl groups from NF-kB p65, as
(i) HDAC3 deacetylates p65 NF-kB at all known lysine
residues; (ii) 19 (48%) of 40 HDAC3-dependent
IL-1 response genes require p65 for expression (Sup-
plementary Table S1); and (iii) mimicking acetylation
of p65 at these sites results in p65 variants with
strongly diminished gene-activating properties for inﬂam-
matory genes. The p65 5KQ mutant is not generally
Figure 9. Continued.
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transcriptionally inactive, as a recently published gene
array analysis in reconstituted and TNF-stimulated cells
showed that p65 5KQ was able to induce the
TNF-stimulated genes Ccl9 and Mmp9 at levels compar-
able with the wild-type p65 protein (15). Here, we
extended this analysis and found a larger group of
genes whose constitutive p65 NF-kB-dependent expres-
sion was enhanced by either the K4Q or the K5Q
mutant (Figure 9). These data exclude non-speciﬁc and
general functional defects for the p65 K-Q mutants and
underscore their suitability as gain-of-function mutants
mimicking p65 acetylations. Of note, data acquired
with the p65 K/R mutants are more difﬁcult to interpret,
as they reﬂect defective acetylation and strongly impaired
ubiquitination (15). This also relates to ﬁndings on the
role of K122 and K123, which have been previously
implicated in a mechanism involving IkB-mediated
removal of p65 from the IL-8 promoter on the basis of
KK122/123/RR mutations (9). These mutations may
either affect p65:chromatin interactions or alter degrad-
ation of promoter bound p65 (55). This may also explain
why so far the functional exploration of p65 acetylation
(which thus far has only been addressed by the use of K/
R mutants) has not revealed a coherent picture (5,7,8,12).
Thus, the data provided in this study using K-Q muta-
tions provide novel evidence for speciﬁc gene-regulatory
functions of p65 acetylations.
Research on p65 acetylation has also been limited, as
primarily, the acetylation site K310 was investigated
owing to the availability of a speciﬁc antibody
(10,11,16,56). Here, using two other speciﬁc antibodies
developed by us (12,14), we show that modiﬁcations at
K314 and K315 play a different role. Like for K310,
acetylation at these sites is removed by HDAC3. But in
contrast to acetylation of K310, which activates transcrip-
tion of the cIAP-2 gene (57), we show here by means of the
K4Q mutant and by individual K-Q mutants that acetyl-
ation at K314 and K315 in addition to acetylation of
K122 and K123 negatively regulate p65 functions at in-
ﬂammatory target genes. Of note, detection of acetylation
of p65 requires overexpression of HATs and p65
(Figure 4), suggesting that acetylation is a low abundant
and transient event that affects only a fraction of all p65
protein present in the cell.
HDAC3 can be found in the cytosol and in the nucleus
(28), but the subcellular compartment for HDAC3-
mediated regulation of the p65 acetylation status is pres-
ently not known. Our data show that most of the HDAC3
protein in epithelial cells is found in the nucleus
(Figure 6B) but does not stably associate with chromatin
(Figure 6C). Moreover, a DNA-binding defective p65
point mutant (p65 E39I) is still deacetylated by HDAC3
(Supplementary Figure S8), arguing that deacetylation
must not necessarily occur at chromatin-bound p65.
Like most classical HDACs, HDAC3 is contained in
large high molecular weight co-repressor complexes of
up to 1–2 MDa (21,23,25,26). HDAC5 and HDAC8 did
not deacetylate p65 in our assay systems, whereas HDAC1
and HDAC2 also deacetylated p65 at lysines K314 or
K315 (Supplementary Figure S9). As knockdown of
HDAC1 and HDAC2 also impairs IL-1-inducible Cxcl2
expression (Supplementary Figure S10), it will be interest-
ing to deﬁne the individual roles of other regulators of p65
acetylation for gene expression in future studies. Of note,
we also observed HDAC3-regulated genes, which are not
p65-dependent (Supplementary Table S1), thus showing
that HDAC3 operates also by further p65-independent
mechanisms.
During the course of this study, we also noted
that IL-1-induced genes were more strongly affected
by HDAC3 suppression than TNF-induced genes
(Supplementary Figure S11). IL-1 and TNF activate
overlapping sets of proinﬂammatory genes and share
many signaling components, but emerging evidence also
suggests speciﬁc pathways as exempliﬁed by usage of dif-
ferent E2 and E3 ubiquitination enzymes in their NF-kB
activating pathways (58). It will therefore be interesting to
clarify a speciﬁc role of HDAC3 in cytokine pathways in
future studies.
In line with emerging functions of HDAC3 in innate
immunity, deletion of the enzyme in macrophages was
recently shown to affect histone acetylation leading to
the expression of a set of IL-4-regulated genes. These
ﬁndings demonstrate a speciﬁc role of HDAC3 in
controlling macrophage polarization involving epigenetic
mechanisms (59). Our study now reveals an unexpected
role of HDAC3 for the control of IL-1-triggered
pro-inﬂammatory gene expression. Apparently, the IL-1
pathway directs the recruitment of HDAC3 into
gene-regulatory complexes distinct from the known
co-repressor complexes. At present, the nature of these
co-activator complexes is unknown and may not require
stable association with chromatin. This non-epigenetic
effect is of biomedical relevance, as non-selective HDAC
inhibitors are used as anti-cancer drugs and are currently
tested in a number of clinical trials for the treatment of
further diseases (46,60). As an example, clinical data show
anti-inﬂammatory properties of HDAC inhibitors that
can be used for the treatment of graft versus host
disease (61). In addition, animal models have revealed
strong anti-inﬂammatory effects by pharmacological
modulators of HDAC activity (62). HDAC inhibitors
show antiphlogistic efﬁcacy in models of inﬂammatory
bowel disease (63) and of rheumatoid arthritis (64).
Chemokines such as IL-8 or CXCL2 mediate leukocyte
trafﬁcking, leukocyte inﬁltration, angiogenesis or metasta-
sis (65–67). Hence, IL-1-driven signaling mechanisms,
which control the magnitude and kinetics of expression
of these chemokines are important modulators of disease
processes. By demonstrating a general role of HDAC3 in
positive regulation of IL-1 responses at the cellular level,
this study contributes novel insights into the molecular
mechanisms underlying anti-inﬂammatory effects of
HDAC inhibition.
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